Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACDC: Early Surgery vs Antibiotics in Acute Cholecystitis
NCT00447304Phase 3Completed
- Sponsor
- Heidelberg University
- Start
- Oct 2006
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of moxifloxacin in acute cholecystitis (2 arms), sponsored by Heidelberg University. Primary endpoint: Morbidity at the test-of-cure visit at Day 75. Started Oct 2006; status: completed.
02
Drugs
moxifloxacin
03
Conditions
acute cholecystitis
Beyond the preview
Go deeper on NCT00447304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447304.